Price to Book Value (P/BV)
since 2005
Calculation
Thermo Fisher Scientific Inc., P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Thermo Fisher Scientific Inc. shareholders’ equity1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 | 4.57 | = | 560.49 | ÷ | 122.56 | 122.56 | = | 46,735 | ÷ | 381,312,268 | |
| Feb 23, 2023 | 4.83 | = | 550.95 | ÷ | 114.10 | 114.10 | = | 43,978 | ÷ | 385,430,077 | |
| Feb 24, 2022 | 5.18 | = | 540.17 | ÷ | 104.28 | 104.28 | = | 40,793 | ÷ | 391,191,770 | |
| Feb 25, 2021 | 5.15 | = | 451.47 | ÷ | 87.63 | 87.63 | = | 34,507 | ÷ | 393,793,362 | |
| Feb 26, 2020 | 4.16 | = | 309.16 | ÷ | 74.41 | 74.41 | = | 29,675 | ÷ | 398,828,389 | |
| Feb 27, 2019 | 3.75 | = | 259.14 | ÷ | 69.14 | 69.14 | = | 27,586 | ÷ | 399,003,681 | |
| Feb 28, 2018 | 3.30 | = | 208.58 | ÷ | 63.25 | 63.25 | = | 25,413 | ÷ | 401,784,066 | |
| Feb 28, 2017 | 2.86 | = | 157.68 | ÷ | 55.17 | 55.17 | = | 21,539 | ÷ | 390,391,061 | |
| Feb 25, 2016 | 2.42 | = | 130.57 | ÷ | 53.88 | 53.88 | = | 21,350 | ÷ | 396,261,928 | |
| Feb 26, 2015 | 2.51 | = | 130.14 | ÷ | 51.79 | 51.79 | = | 20,548 | ÷ | 396,782,757 | |
| Feb 27, 2014 | 2.90 | = | 124.91 | ÷ | 43.02 | 43.02 | = | 16,856 | ÷ | 391,792,194 | |
| Feb 27, 2013 | 1.72 | = | 74.25 | ÷ | 43.24 | 43.24 | = | 15,465 | ÷ | 357,625,034 | |
| Feb 29, 2012 | 1.38 | = | 56.62 | ÷ | 41.10 | 41.10 | = | 15,038 | ÷ | 365,853,610 | |
| Feb 24, 2011 | 1.41 | = | 55.33 | ÷ | 39.33 | 39.33 | = | 15,361 | ÷ | 390,607,016 | |
| Feb 26, 2010 | 1.29 | = | 48.77 | ÷ | 37.69 | 37.69 | = | 15,431 | ÷ | 409,461,414 | |
| Feb 27, 2009 | 1.02 | = | 36.26 | ÷ | 35.70 | 35.70 | = | 14,927 | ÷ | 418,164,910 | |
| Feb 29, 2008 | 1.62 | = | 55.93 | ÷ | 34.61 | 34.61 | = | 14,488 | ÷ | 418,600,105 | |
| Mar 1, 2007 | 1.38 | = | 45.56 | ÷ | 33.12 | 33.12 | = | 13,912 | ÷ | 420,030,996 | |
| Mar 2, 2006 | 2.03 | = | 34.78 | ÷ | 17.16 | 17.16 | = | 2,793 | ÷ | 162,738,621 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Thermo Fisher Scientific Inc. Annual Report.
Comparison to Competitors
Thermo Fisher Scientific Inc., P/BV, long-term trends, comparison to competitors
| Thermo Fisher Scientific Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 | 4.57 | 29.97 | 24.94 | 3.35 | 3.47 | 65.80 | 4.01 | 5.48 | 8.68 | 2.66 | 1.75 | 3.96 |
| Feb 23, 2023 | 4.83 | 15.52 | 35.01 | 4.88 | 3.64 | 29.36 | 4.90 | 5.37 | 6.07 | 2.81 | 2.48 | 3.77 |
| Feb 24, 2022 | 5.18 | 16.53 | 18.51 | 4.07 | 4.16 | 25.28 | 3.65 | 5.90 | 5.05 | 4.31 | 3.35 | 3.60 |
| Feb 25, 2021 | 5.15 | 14.18 | 14.53 | 3.55 | 3.93 | 35.07 | 4.33 | 6.72 | 7.46 | 24.16 | 2.98 | 4.81 |
| Feb 26, 2020 | 4.16 | — | 13.84 | 2.80 | 3.72 | 51.67 | 3.93 | 6.61 | 7.83 | 8.21 | 3.00 | 3.79 |
| Feb 27, 2019 | 3.75 | — | 9.41 | 5.89 | 2.80 | 12.87 | 3.89 | 6.08 | 7.79 | 4.29 | 3.80 | 5.07 |
| Feb 28, 2018 | 3.30 | 36.95 | 5.02 | 8.88 | 2.58 | 7.33 | 5.15 | 5.79 | 4.30 | — | 2.94 | 5.66 |
| Feb 28, 2017 | 2.86 | 21.24 | 4.14 | 5.66 | 2.56 | 6.33 | 4.88 | 4.72 | 4.51 | — | 3.40 | 8.58 |
| Feb 25, 2016 | 2.42 | 22.17 | 3.94 | 7.04 | 2.53 | 5.51 | 6.59 | 4.07 | 3.15 | — | 2.84 | 10.53 |
| Feb 26, 2015 | 2.51 | 56.09 | 4.59 | 6.72 | 2.63 | 5.14 | 10.08 | 4.01 | 3.42 | — | 2.95 | 16.22 |
| Feb 27, 2014 | 2.90 | 18.05 | 4.30 | 5.92 | 2.38 | 3.69 | 11.36 | 3.50 | 3.35 | — | 2.69 | 16.74 |
| Feb 27, 2013 | 1.72 | 18.06 | 3.57 | 4.40 | 2.23 | 4.15 | 7.01 | 3.29 | 2.44 | — | 2.42 | 12.91 |
| Feb 29, 2012 | 1.38 | — | 2.83 | 3.50 | 2.17 | 3.35 | 5.08 | 3.13 | 2.14 | — | 1.95 | 19.19 |
| Feb 24, 2011 | 1.41 | — | 2.04 | 2.76 | 2.39 | 3.21 | 5.29 | 2.88 | 1.85 | — | 1.75 | 6.42 |
| Feb 26, 2010 | 1.29 | — | 2.46 | 2.88 | 2.07 | 4.17 | 6.74 | 3.45 | 1.97 | — | 1.57 | 5.49 |
| Feb 27, 2009 | 1.02 | — | 2.48 | 3.29 | 1.69 | 5.01 | 9.83 | 3.56 | 2.72 | — | 1.44 | 2.94 |
| Feb 29, 2008 | 1.62 | — | 2.77 | 4.22 | 2.62 | 4.16 | 11.76 | 4.17 | 5.38 | — | 2.32 | 3.24 |
| Mar 1, 2007 | 1.38 | — | 3.96 | 5.50 | 3.32 | 5.43 | 18.07 | 4.78 | 5.45 | — | 2.49 | 5.77 |
| Mar 2, 2006 | 2.03 | — | 4.26 | 4.00 | 3.78 | 5.85 | 9.18 | 4.66 | 4.30 | — | 2.94 | 8.16 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Thermo Fisher Scientific Inc., P/BV, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Thermo Fisher Scientific Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 22, 2024 | 4.57 | 6.66 |
| Feb 23, 2023 | 4.83 | 5.54 |
| Feb 24, 2022 | 5.18 | 5.66 |
| Feb 25, 2021 | 5.15 | 6.13 |
| Feb 26, 2020 | 4.16 | 5.74 |
| Feb 27, 2019 | 3.75 | 5.93 |
| Feb 28, 2018 | 3.30 | 5.04 |
| Feb 28, 2017 | 2.86 | 4.52 |
| Feb 25, 2016 | 2.42 | 4.10 |
| Feb 26, 2015 | 2.51 | 4.40 |
| Feb 27, 2014 | 2.90 | 3.93 |
| Feb 27, 2013 | 1.72 | 3.19 |
| Feb 29, 2012 | 1.38 | 2.53 |
| Feb 24, 2011 | 1.41 | 2.23 |
| Feb 26, 2010 | 1.29 | 2.35 |
| Feb 27, 2009 | 1.02 | 2.58 |
| Feb 29, 2008 | 1.62 | 3.41 |
| Mar 1, 2007 | 1.38 | 3.81 |
| Mar 2, 2006 | 2.03 | 3.98 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Thermo Fisher Scientific Inc., P/BV, long-term trends, comparison to industry (health care)
| Thermo Fisher Scientific Inc. | Health Care | |
|---|---|---|
| Feb 22, 2024 | 4.57 | 5.13 |
| Feb 23, 2023 | 4.83 | 71,951.01 |
| Feb 24, 2022 | 5.18 | 4.78 |
| Feb 25, 2021 | 5.15 | 4.66 |
| Feb 26, 2020 | 4.16 | 4.41 |
| Feb 27, 2019 | 3.75 | 4.42 |
| Feb 28, 2018 | 3.30 | 4.25 |
| Feb 28, 2017 | 2.86 | 3.83 |
| Feb 25, 2016 | 2.42 | 3.47 |
| Feb 26, 2015 | 2.51 | 3.90 |
| Feb 27, 2014 | 2.90 | 3.30 |
| Feb 27, 2013 | 1.72 | 2.70 |
| Feb 29, 2012 | 1.38 | 2.38 |
| Feb 24, 2011 | 1.41 | 2.11 |
| Feb 26, 2010 | 1.29 | 2.23 |
| Feb 27, 2009 | 1.02 | 2.42 |
| Feb 29, 2008 | 1.62 | 3.26 |
| Mar 1, 2007 | 1.38 | 3.75 |
| Mar 2, 2006 | 2.03 | 3.89 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).